Cedar Fair LP
Change company Symbol lookup
Select an option...
FUN Cedar Fair LP
BAC Bank of America Corp
XLF Financial Select Sector SPDR® Fund
FRAN Francesca's Holdings Corp
ED Consolidated Edison Inc
BIIB Biogen Inc
CNF CNFinance Holdings Ltd
LVS Las Vegas Sands Corp
AZDDQ Azure Dynamics Corp
$DWACSMN Dorsey Wright Country Stock NTRIndex
Go

Consumer Discretionary : Hotels, Restaurants & Leisure | Small Cap Blend
Company profile

Cedar Fair, L.P. is an operator of regional amusement parks. The Company operates within a segment of amusement/water parks with accompanying resort facilities. As of December 31, 2016, the Company owned approximately 11 amusement parks, two separately gated outdoor water parks, one indoor water park and five hotels. The amusement parks include Cedar Point, located on Lake Erie between Cleveland and Toledo in Sandusky, Ohio; Knott's Berry Farm, near Los Angeles, California; Canada's Wonderland, near Toronto, Canada; Kings Island, near Cincinnati, Ohio; Carowinds, in Charlotte, North Carolina; Dorney Park & Wildwater Kingdom (Dorney Park), in Allentown, Pennsylvania; Kings Dominion, near Richmond, Virginia; California's Great America, in Santa Clara, California; Valleyfair, near Minneapolis/St. Paul, Minnesota; Worlds of Fun, in Kansas City, Missouri, and Michigan's Adventure, in Muskegon, Michigan. It manages and operates Gilroy Gardens Family Theme Park in Gilroy, California.

Closing Price
$28.26
Day's Change
0.07 (0.25%)
Bid
--
Ask
--
B/A Size
--
Day's High
29.90
Day's Low
28.13
Volume
(Below Average)
Volume:
591,624

10-day average volume:
718,399
591,624

Vaxart's stock rockets on heavy volume after initiating coronavirus vaccine development program

2:08 pm ET January 31, 2020 (MarketWatch)
Print

Shares of Vaxart Inc. (VXRT) rocketed 54% on heavy volume in afternoon trading, putting them on track for the first close above the $1 mark in nearly 10 months, after the biotechnology company said it "initiated" a program to develop a coronavirus vaccine (http://www.marketwatch.com/story/coronavirus-update-213-people-have-died-countries-recommend-against-travel-and-pilots-sue-over-continued-flights-to-china-2020-01-31). Trading volume was inflated to 57.7 million shares, compared with the full-day average over the past 30 days of 3.7 million shares. The company said it will develop a vaccine candidate based on its oral vaccine platform, VAAST, which it has used to conduct multiple clinical trials. "We believe our oral tablet vaccines provide substantial potential advantages, especially when targeting mucosal pathogens such as flu, norovirus, RSV and the recently emerged coronavirus,"said Chief Executive Wouter Latour. "In addition, the logistical advantages of an oral vaccine that is administered using a convenient room temperature-stable tablet could be of critical benefit when rolling out a major public health vaccination campaign." The stock has now run up 251% over the past three months, while the iShares Nasdaq Biotechnology ETF (IBB) has gained 5.6% and the S&P 500 has tacked on 6.5%.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

January 31, 2020 14:08 ET (19:08 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.